These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 20094873)

  • 1. Therapeutic potential of HDPs as immunomodulatory agents.
    Jenssen H; Hancock RE
    Methods Mol Biol; 2010; 618():329-47. PubMed ID: 20094873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential therapeutic application of host defense peptides.
    Zhang L; Falla TJ
    Methods Mol Biol; 2010; 618():303-27. PubMed ID: 20094872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multifunctional cationic host defence peptides and their clinical applications.
    Yeung AT; Gellatly SL; Hancock RE
    Cell Mol Life Sci; 2011 Jul; 68(13):2161-76. PubMed ID: 21573784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using antimicrobial host defense peptides as anti-infective and immunomodulatory agents.
    Kruse T; Kristensen HH
    Expert Rev Anti Infect Ther; 2008 Dec; 6(6):887-95. PubMed ID: 19053901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Host defense peptides and their antimicrobial-immunomodulatory duality.
    Steinstraesser L; Kraneburg U; Jacobsen F; Al-Benna S
    Immunobiology; 2011 Mar; 216(3):322-33. PubMed ID: 20828865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Porcine host defense peptides: expanding repertoire and functions.
    Sang Y; Blecha F
    Dev Comp Immunol; 2009 Mar; 33(3):334-43. PubMed ID: 18579204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies.
    Hancock RE; Sahl HG
    Nat Biotechnol; 2006 Dec; 24(12):1551-7. PubMed ID: 17160061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Host defense peptides for use as potential therapeutics.
    Zhang L; Falla TJ
    Curr Opin Investig Drugs; 2009 Feb; 10(2):164-71. PubMed ID: 19197794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cationic host defence peptides: multifaceted role in immune modulation and inflammation.
    Choi KY; Chow LN; Mookherjee N
    J Innate Immun; 2012; 4(4):361-70. PubMed ID: 22739631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging themes and therapeutic prospects for anti-infective peptides.
    Yount NY; Yeaman MR
    Annu Rev Pharmacol Toxicol; 2012; 52():337-60. PubMed ID: 22235859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multifunctional host defense peptides: antimicrobial peptides, the small yet big players in innate and adaptive immunity.
    Auvynet C; Rosenstein Y
    FEBS J; 2009 Nov; 276(22):6497-508. PubMed ID: 19817855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial peptides: properties and applicability.
    van 't Hof W; Veerman EC; Helmerhorst EJ; Amerongen AV
    Biol Chem; 2001 Apr; 382(4):597-619. PubMed ID: 11405223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of host defense peptides of the innate immune response in sepsis.
    Hirsch T; Metzig M; Niederbichler A; Steinau HU; Eriksson E; Steinstraesser L
    Shock; 2008 Aug; 30(2):117-26. PubMed ID: 18091568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The immunology of host defence peptides: beyond antimicrobial activity.
    Hancock RE; Haney EF; Gill EE
    Nat Rev Immunol; 2016 May; 16(5):321-34. PubMed ID: 27087664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-endotoxin properties of cationic host defence peptides and proteins.
    Bowdish DM; Hancock RE
    J Endotoxin Res; 2005; 11(4):230-6. PubMed ID: 16176660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cationic antimicrobial peptides: from innate immunity study to drug development. Up date].
    Andrès E; Dimarcq JL
    Med Mal Infect; 2007 Apr; 37(4):194-9. PubMed ID: 17306486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial peptide elicitors: new hope for the post-antibiotic era.
    Prado Montes de Oca E
    Innate Immun; 2013 Jun; 19(3):227-41. PubMed ID: 23160387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial activity of the recombinant designer host defence peptide P-novispirin G10 in infected full-thickness wounds of porcine skin.
    Jacobsen F; Mohammadi-Tabrisi A; Hirsch T; Mittler D; Mygind PH; Sonksen CP; Raventos D; Kristensen HH; Gatermann S; Lehnhardt M; Daigeler A; Steinau HU; Steinstraesser L
    J Antimicrob Chemother; 2007 Mar; 59(3):493-8. PubMed ID: 17289767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.